InVivo Therapeutics has submitted an updated Investigational Device Exemption (IDE) to the U.S. Food and Drug Administration (FDA) requesting permission to begin human studies in order to test its biopolymer scaffolding for the treatment of acute SCI. “We intend to…
Month: February 2013
Courtine's electrical stimulation therapy that enabled paralysed rats to walk again will be tested on humans within months
In June we were excited about research from Gregoire Courtine’s lab in Switzerland, which demonstrated full recovery of rats with SCI after a drug cocktail was coupled with electrical stimulation of the spinal cord below the level of injury. After two…
StemCells, Inc. announces results of spinal cord injury trial – gains in sensory function persist 12 months after stem cell transplant
StemCells Inc. have announced the 12-month results of their initial Phase I safety trial of purified human neural stem cells for chronic spinal cord injury. The sensory improvements reported at 6-months have persisted and not adverse effects have be seen.…
Reflex control could improve walking after incomplete spinal injuries
A training regimen to adjust the body’s motor reflexes may help improve mobility for some people with incomplete spinal cord injuries, according to a study supported by the National Institutes of Health. During training, the participants were instructed to suppress…